DHODH and rheumatoid arthritis: It is important to note that DHODH-based therapy is most likely a safe approach, since the DHODH inhibitor leflunomide and its active metabolite teriflunomide have been used clinically for chronic diseases, such as rheumatoid arthritis and multiple sclerosis [54, 55].